Lv1
20 积分 2022-04-10 加入
Dectin-1: a signalling non-TLR pattern-recognition receptor
5天前
已完结
CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma
5天前
已完结
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
10天前
已完结
Glofitamab CD20-TCB bispecific antibody
10天前
已完结
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
18天前
已完结
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma
1个月前
已完结
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumors
2个月前
已完结
PD-1 and PD-1 ligands: from discovery to clinical application
2个月前
已完结
Targeting VSIG4(+) tissue-resident macrophages enhances T cell cytotoxicity and immunotherapy efficacy in cancer
2个月前
已完结
VSIG4 restricts hepatocellular carcinoma control by suppressing tumor-specific CD8+ T cell immunity in the tumor microenvironment
2个月前
已完结
皖公网安备34019202002308
